The Patent Finder
US

Manufacture of Peanut Formulations for Oral Desensitization

US 10,449,118 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Mar 12, 2034 · Low confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Oct 24, 2017 as application 15/792,716 · Granted Oct 22, 2019
Base term, 20 years from filing
Today
20 years from filing
2014 2034
Clock starts
Mar 12, 2014
Ends no later than
Mar 12, 2034
Granted
Oct 22, 2019
base term fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 12, 2014, when application 14/207,165, the earliest non-provisional in its chain, was filed (this one was filed Oct 24, 2017); a parent in its chain could not be resolved (the next row)Mar 12, 2034High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Mar 12, 2034Low confidence

This family

US 9,198,869In force
no later than Mar 2034
no later than Mar 2034
Application 14/881,437Abandoned
not computed
not computed
US 10,449,118this patent
no later than Mar 2034
no later than Mar 2034
US 11,141,352In force
no later than Mar 2034
no later than Mar 2034
Application 17/412,170Abandoned
not computed
not computed
Application 17/591,357Abandoned
not computed
not computed
Application 17/861,041Abandoned
not computed
not computed
Application 17/948,611Abandoned
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 9, 2018
Reel 44883, frame 84
Walser, Bryan; Raff, Howard V.Allergen Research CorporationAssignment of Assignor's Interest
Feb 9, 2018
Reel 45299, frame 57
Allergen Research CorporationAimmune Therapeutics, Inc.Change of Name
Jan 4, 2019
Reel 47906, frame 433
Aimmune Therapeutics, Inc.Cortland Capital Market Services LLCSecurity Interest
Oct 13, 2020
Reel 54064, frame 106
Cortland Capital Market Services LLCAimmune Therapeutics, Inc.Release of Security Interest in Patent Collateral
Feb 21, 2022
Reel 59057, frame 590
Aimmune Therapeutics, Inc.Société des Produits Nestlé S.A.Assignment of Assignor's Interest
Aug 11, 2022
Reel 60781, frame 836
Aimmune Therapeutics, Inc.Societe des Produits Nestle S.A.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited